E

Enzymatica AB (publ)
STO:ENZY

Watchlist Manager
Enzymatica AB (publ)
STO:ENZY
Watchlist
Price: 1.8 SEK 3.45% Market Closed
Market Cap: 436.9m SEK
Have any thoughts about
Enzymatica AB (publ)?
Write Note

Relative Value

The Relative Value of one ENZY stock under the Base Case scenario is 3.46 SEK. Compared to the current market price of 1.8 SEK, Enzymatica AB (publ) is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ENZY Relative Value
Base Case
3.46 SEK
Undervaluation 48%
Relative Value
Price
E
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
19
Median 3Y
16.7
Median 5Y
21.6
Industry
2.5
Forward
8.6
vs History
vs Industry
Median 3Y
-14.9
Median 5Y
-23.1
Industry
21.9
Forward
-6
vs History
vs Industry
Median 3Y
-18.3
Median 5Y
-24.8
Industry
16.5
vs History
vs Industry
Median 3Y
-19.4
Median 5Y
-20.7
Industry
23.6
vs History
96
vs Industry
18
Median 3Y
8.9
Median 5Y
10.8
Industry
2.1
vs History
96
vs Industry
17
Median 3Y
16.7
Median 5Y
20.7
Industry
2.6
Forward
6.7
vs History
96
vs Industry
17
Median 3Y
26.2
Median 5Y
32.7
Industry
5.2
vs History
vs Industry
Median 3Y
-15.1
Median 5Y
-23.3
Industry
13.3
Forward
-6.3
vs History
vs Industry
Median 3Y
-15.1
Median 5Y
-22.4
Industry
16.6
Forward
-6.1
vs History
vs Industry
Median 3Y
-18.5
Median 5Y
-24.1
Industry
15.6
vs History
vs Industry
Median 3Y
-17.8
Median 5Y
-22.6
Industry
19.1
vs History
96
vs Industry
24
Median 3Y
7.6
Median 5Y
9.3
Industry
1.9

Multiples Across Competitors

ENZY Competitors Multiples
Enzymatica AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Enzymatica AB (publ)
STO:ENZY
436.9m SEK 9.9 -8.1 -6.5 -6.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
SE
E
Enzymatica AB (publ)
STO:ENZY
Average P/E: 32.4
Negative Multiple: -8.1
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top